Larvol Delta - An-Open-Label-Multicenter-Study-to-Evaluate-the-Pharmacokinetics-Efficacy-and-Safety-of-ASCENIV-IGIV-in-Pediatric-Subjects-With-Primary-Immunodeficiency-Diseases-PIDD

Asceniv (intravenous immunoglobulin) - ADMA Biologics

http://clinicaltrials.gov/ct2/show/NCT05070455

Sep 16, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next